Podcasts / The AZ Vaccine – Clot risks and questions about herd immunity – Lecture
Dr Michelle Ananda-Rajah, will walk us through the data, help us understand our role as GPs and look at what can be done to get our patients and the country back on track to long term protection against COVID19. The AZ vaccine is a key part of the Australian COVID prevention strategy. However, we must ask ourselves whether or not the risk of adverse effects, especially clots, is acceptable in the Australian context where COVID is more or less under control. This is a vital issue to grasp if we are to make reliable recommendations to our patients. Furthermore, we must take a close look at whether or not the efficacy of the AZ vaccine is high enough for us to achieve herd immunity. As the public becomes increasingly hesitant with regard to the AZ vaccine, the likelihood of us vaccinating enough of the population to achieve herd immunity diminishes rapidly.
TIAs and Carotid Stenosis
Low libido - What is it & How is it Managed?
Functional Gastrointestinal Disorders in Infants – Practical Advice for HCPs
Using the New RSV Vaccine in Practice
expert
Infectious Diseases and General Medicine Physician; Founder, fungalAi; Co-Founder, Healthcare Workers Australia
Browse the latest podcasts from Healthed.
You have completed the Educational Activities component of this resource.
Select ‘Confirm & claim CPD‘ to confirm you have engaged with this resource in its entirety and claim your CPD.
You will be taken to explore further CPD learning available to you.